CRISPR-Cas9 protein (NLS,EGFP)
-
- Target
- CRISPR-Cas9
- Protein-Typ
- Recombinant
-
Spezies
- Streptococcus pyogenes
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- NLS,EGFP
- Applikation
- Genome Editing with Engineered Nucleases (GEEN)
- Verwendungszweck
- NLS-Cas9-EGFP Nuclease
- Produktmerkmale
- Fusion protein Cas9 nuclease expressed in an Escherichia coli with a N terminal end nuclear localization signal (NLS) and a C terminal end an EGFP.
- Aufreinigung
- Escherichia coli expression system
-
-
- Applikationshinweise
-
CRISPR Genomic editing
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In 10 mM Tris, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, pH 7.4 (50 % glycerol).
- Konservierungsmittel
- Dithiothreitol (DTT)
- Vorsichtsmaßnahmen
- This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- CRISPR-Cas9
- Andere Bezeichnung
- Cas9 nuclease
-